rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Pavan Cheruvu

Director

Company insider

Files Form 4 as: Director, Retension Pharmaceuticals; Chief Executive Officer, Sio Gene Therapies.

Every Form 4 they filed

In numbers

Trades disclosed
19
Buys
3
Sells
0
Bought
$390K
Sold
$0
Companies
2
Companies where not an officer
1
First trade
13 Feb 2018
Last trade
13 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
Sio Gene TherapiesDirector, Officer · last 8 Dec 20213 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
RTSN Retension PharmaceuticalsDirector · Biotechnology · last 13 Oct 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 Oct 2026filed 13 Oct 2026RTSN Retension Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—5,636 at $0.00filing
8 Dec 2021filed 9 Dec 2021Sio Gene Therapiesoption or derivativeSEC FORM 4 Code D—37,567 at $0.00filing
8 Dec 2021filed 9 Dec 2021Sio Gene TherapiesSEC FORM 4 Code A—37,567 at $0.00filing
8 Dec 2021filed 9 Dec 2021Sio Gene TherapiesSEC FORM 4 Code F$21K14,884 at $1.42filing
15 Apr 2021filed 19 Apr 2021Sio Gene Therapiesoption or derivativeSEC FORM 4 Code A—682,100 at $0.00filing
23 Mar 2021filed 24 Mar 2021Sio Gene TherapiesSEC FORM 4 Bought$248K100,000 at $2.48filing
17 Mar 2021filed 19 Mar 2021Sio Gene TherapiesSEC FORM 4 Code A—22,590 at $0.00filing
17 Mar 2021filed 19 Mar 2021Sio Gene Therapiesoption or derivativeSEC FORM 4 Code D—22,590 at $0.00filing
8 Jul 2020filed 10 Jul 2020Axovant Gene TherapiesSEC FORM 4 Bought$103K37,500 at $2.74filing
11 Jun 2020filed 15 Jun 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code D—22,591 at $0.00filing
11 Jun 2020filed 15 Jun 2020Axovant Gene TherapiesSEC FORM 4 Code A—22,591 at $0.00filing
11 Jun 2020filed 15 Jun 2020Axovant Gene TherapiesSEC FORM 4 Code F$30K9,755 at $3.09filing
15 Apr 2020filed 17 Apr 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—169,100 at $0.00filing
15 Apr 2020filed 17 Apr 2020Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—112,700 at $0.00filing
21 Sep 2019filed 24 Sep 2019Axovant Gene Therapiesoption or derivativeSEC FORM 4 Code A—45,181 at $0.00filing
14 Jun 2019filed 17 Jun 2019Axovant Gene TherapiesSEC FORM 4 Bought$39K7,500 at $5.21filing
15 Apr 2019filed 17 Apr 2019Axovant Sciencesoption or derivativeSEC FORM 4 Code A—1,596,000 at $0.00filing
15 Apr 2019filed 17 Apr 2019Axovant Sciencesoption or derivativeSEC FORM 4 Code A—1,596,000 at $0.00filing
13 Feb 2018filed 15 Feb 2018Axovant Sciencesoption or derivativeSEC FORM 4 Code A—1,940,185 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.